Navigation Links
Landauer, Inc. Declares Regular Cash Dividend
Date:2/26/2010

GLENWOOD, Ill., Feb. 26 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.5375 per share for the second quarter of fiscal 2010.  The dividend will be paid on April 2, 2010, to shareholders of record on March 12, 2010.

About Landauer

Landauer is the world's leading provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services.   For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees.  Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.  The Company provides its dosimetry services to approximately 1.6 million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia, Mexico and other countries.  In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and diagnostic physics services and educational services to the medical physics community.  

SOURCE Landauer, Inc.

Back to top

RELATED LINKS
http://www.landauerinc.com

'/>"/>

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Landauer, Inc. Reports Fiscal 2009 Third Quarter Results
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2009 Results
3. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2009 Results
4. Landauer, Inc. Declares Regular Cash Dividend
5. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2009 Results
6. Landauer, Inc. Increases Regular Cash Dividend and Declares First Quarter Payment
7. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2008 Results
8. Landauer, Inc. Declares Regular Cash Dividend
9. Landauer, Inc. Declares Regular Cash Dividend
10. Landauer, Inc. Reports Record Results for Second Quarter
11. Landauer, Inc. Declares Regular Cash Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... Edward D. Buckingham, M.D ... America's Best Physicians. The annual roster is put out by the National Consumer Advisory ... commitment to outstanding care are considered for this award. , The National Consumer Advisory ...
(Date:5/23/2016)... ... May 23, 2016 , ... Researchers can find themselves in a state of ... at this technique may yield big benefits. Scientists might be surprised to learn how ... cell culture laboratory—and lessen the risk of contamination when working with eukaryotic cells. , ...
(Date:5/23/2016)... ... 2016 , ... In light of National Heat Awareness Day ... intervening at the first sign of their pet overheating is the key to ... keep the body’s temperature within a safe range. Considered a veterinary emergency, heatstroke ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... May 23, 2016 , ... Hadley Institute for the Blind ... are blind or visually impaired, announces the election of Julie S. Tye as ... Hadley’s Board of Trustees retained Morris & Berger, a firm specializing in non-profit ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... JERUSALEM , May 23, 2016 ... DNA for detection of multiple diseases; ,Technology to be ... Yissum Research Development Company of the ... entered into a research agreement with Aurum Ventures MKI, the ... the development of a new diagnostic approach for early ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
(Date:5/20/2016)... 2016 ReportsnReports.com adds "Plaque ... market research report with comprehensive information on the ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
Breaking Medicine Technology: